Tactile Systems Technology, Inc. (TCMD) stock declined over -1.38%, trading at $25.65 on NASDAQ, down from the previous close of $26.01. The stock opened at $25.65, fluctuating between $25.53 and $26.28 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 08, 2026 | 26.01 | 26.28 | 25.51 | 25.65 | 384.76K |
| May 07, 2026 | 26.96 | 27.57 | 25.77 | 26.01 | 595.98K |
| May 06, 2026 | 24.26 | 25.34 | 23.76 | 25.30 | 481.05K |
| May 05, 2026 | 21.43 | 24.67 | 20.53 | 24.05 | 967.12K |
| May 04, 2026 | 22.85 | 23.00 | 21.91 | 22.43 | 663.9K |
| Apr 30, 2026 | 22.48 | 23.05 | 22.26 | 23.02 | 293.04K |
| Apr 29, 2026 | 23.34 | 23.62 | 22.25 | 22.50 | 359.86K |
| Apr 28, 2026 | 24.19 | 24.29 | 22.96 | 23.57 | 517.39K |
| Apr 27, 2026 | 24.96 | 25.36 | 24.17 | 24.24 | 237.18K |
| Apr 23, 2026 | 24.94 | 25.28 | 24.21 | 24.45 | 183.55K |
| Apr 22, 2026 | 24.89 | 26.00 | 24.74 | 24.96 | 248.55K |
| Apr 21, 2026 | 25.55 | 25.88 | 24.63 | 24.80 | 141.69K |
| Apr 20, 2026 | 25.49 | 26.16 | 25.40 | 25.52 | 106.48K |
| Apr 17, 2026 | 25.30 | 25.94 | 25.27 | 25.73 | 168.67K |
| Apr 16, 2026 | 25.17 | 25.58 | 24.89 | 25.13 | 168.39K |
| Apr 14, 2026 | 24.42 | 25.16 | 24.32 | 25.06 | 393.15K |
| Apr 13, 2026 | 23.43 | 24.48 | 23.26 | 24.24 | 183.51K |
| Apr 10, 2026 | 23.93 | 24.13 | 23.29 | 23.43 | 187.09K |
| Apr 09, 2026 | 24.39 | 24.39 | 23.31 | 23.96 | 254.2K |
| Apr 08, 2026 | 24.83 | 25.41 | 24.07 | 24.14 | 331.16K |
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
| Employees | 1037 |
| Beta | 0.99 |
| Sales or Revenue | $274.42M |
| 5Y Sales Change% | 0.611% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep